Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Dysarthosis

methylprednisolone hemisuccinate has been researched along with Dysarthosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gold, R; Hoepner, R; Krogias, C; Müller, A; Schneider-Gold, C; Schröder, A1

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Dysarthosis

ArticleYear
Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab.
    JAMA neurology, 2013, Volume: 70, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Chorea; Combined Modality Therapy; Dysarthria; Dystonia; Epilepsy; Follow-Up Studies; Humans; Male; Membrane Proteins; Methylprednisolone Hemisuccinate; Middle Aged; Nerve Tissue Proteins; Receptors, Interleukin-6; Remission Induction; Syndrome; Treatment Outcome

2013